AUS
NZ
UK
CA
USA
IND
Healt
RMD Shares on Watch as Healthcare Trends Shift in 2026
June 15, 2026 10:22 AM AEST| By SamResMed continues to attract market attention as healthcare trends evolve, with global demand, digital health growth and valuation debates shaping sentiment across the ASX healthcare sector in 2026.
ASX 200 Health Stocks Turnaround: Why CSL and RMD Are Rising Again
June 14, 2026 05:09 PM AEST| By SamASX healthcare stocks including CSL, Cochlear and ResMed are rebounding after extended weakness, supported by valuation resets, sector rotation and stabilising sentiment across medical and pharmaceutical industries.
CSL Outlook Shift After Impairments Raises Fresh Debate
June 14, 2026 03:55 PM AEST| By SamCSL has revised its earnings outlook following impairments and global market shifts, with US distribution changes and China pricing pressures shaping performance expectations ahead of upcoming financial reporting periods.
ASX 200 Rallies Into Week’s End as CSL Surges and Uranium Stocks Slide
June 14, 2026 10:56 AM AEST| By SamThe ASX 200 posted strong weekly gains led by CSL and consumer stocks, while uranium and growth shares declined amid sector rotation and shifting macro expectations.
Monash IVF Group ASX 300 Updates Earnings Outlook as Sector Activity Softens
June 12, 2026 11:07 AM AEST| By SamMonash IVF Group updated its earnings outlook amid softer fertility sector activity while expanding market share, strengthening international operations and continuing clinical network development initiatives.
Why OncoSil’s Quiet Update Could Signal a Defining Period Ahead
June 12, 2026 11:05 AM AEST| By SamOncoSil enters a crucial phase as regulatory progress, clinical data, manufacturing expansion, and commercial adoption become the central themes shaping its future.
Why ASX Healthcare Stocks Are Back Under the Microscope
June 11, 2026 09:46 PM AEST| By SamHealthcare stocks are being reassessed through the diagnostics and devices theme, with readers focusing on business quality, product adoption, operational discipline and the signals influencing sector sentiment.
Healthcare Stocks Nobody Can Ignore as Valuation Repair Gains Pace
June 11, 2026 09:45 PM AEST| By SamHealthcare stocks are being reassessed through valuation repair, with markets focusing on revenue quality, product adoption, margins and execution as companies work to strengthen confidence across the Australian healthcare sector.
From Trial Hope to Revenue Proof: Why Healthcare Stocks Face a Bigger Test
June 11, 2026 09:43 PM AEST| By SamAustralian healthcare stocks are entering a more evidence-driven phase, with attention shifting towards commercial proof, revenue quality, product adoption and operational execution across leading healthcare businesses.
Why Are These Healthcare Stocks Capturing Market Attention?
June 11, 2026 03:00 PM AEST| By SamSeven healthcare companies spanning biotechnology, diagnostics, hospitals, medical devices, and healthcare software continue drawing attention across Australia's healthcare sector and major market indices.
Which Healthcare Leader Commands More Attention Now?
June 11, 2026 03:00 PM AEST| By SamLeading ASX healthcare companies continue to attract attention through biotechnology, diagnostics, hearing technology and respiratory care, supported by healthcare demand and operational quality.
Bell Potter Backs Cogstate as Healthcare Tech Growth Gains Momentum
June 11, 2026 02:22 PM AEST| By SamCogstate continues building momentum through healthcare technology innovation, strategic partnerships and expanding opportunities across clinical research markets.
Are ASX Healthcare Stocks Rebuilding Strength?
June 11, 2026 02:22 PM AEST| By SamASX healthcare stocks are being reviewed through operational resets, product adoption, hospital activity, diagnostics demand and medical software signals.
Canberra Drone Maker’s ASX Arrival Sparks Fresh Defence Focus
June 11, 2026 09:29 AM AEST| By SamBoresight has entered the ASX as a defence technology company specialising in aerial target drones, with global military customers, expanding manufacturing operations, and a growing role in modern defence training solutions.
ASX Healthcare Innovators 2026: Australia's Global Champions
June 10, 2026 09:55 PM AEST| By SamAustralia's healthcare sector has produced globally recognised leaders through innovation, specialised expertise and international expansion, with CSL, Cochlear, ResMed and Pro Medicus showcasing the country's ability to compete successfully on the w...
The Market’s Quiet Achiever: Why Healthcare Keeps Winning
June 10, 2026 09:53 PM AEST| By Vivek SinghHealthcare combines defensive demand with structural growth from ageing populations and medical innovation. From global healthcare leaders to emerging technology specialists, the sector offers resilience and long-term relevance.
Healthcare's Hidden Comeback Story Few Saw Coming
June 10, 2026 09:51 PM AEST| By SamAustralia's leading healthcare companies faced significant pressure from costs, currency movements and market concerns, yet strong industry fundamentals, demographic trends and enduring healthcare demand continue to support the sector's long-term out...
Kalkine ASX News: Cogstate Ltd (ASX:CGS) Pushes Higher as Healthcare Tech Momentum Build
June 10, 2026 09:41 PM AEST| By SamHighlights,Cogstate attracted strong investor interest as healthcare technology stocks gained momentum on the ASX.,Elevated trading activity highlighted broad market participation in the stock.,The company operates in digital cognitive assessment, su...
Singular Health (ASX:SHG) Expands U.S. Reach as 3DICOM Adoption Accelerates
June 10, 2026 04:18 PM AEST| By Aditi SarkarHighlights,Singular Health Group secured a US$500,000 payment after deploying an additional 500 3DICOM MD® licences across the Provider Network Solutions healthcare network.,The company expanded adoption of 3DICOM MD® within clinical workflows, suppo...
Diagnostics Drive Healthcare Stocks ASX 200 Focus
June 10, 2026 01:55 PM AEST| By SamHealthcare stocks are attracting attention as diagnostics, devices, product adoption, reimbursement settings and clinical evidence become key themes across the Australian healthcare sector.
Advertise your brand on Kalkine Media